VERU INC. Loss Contingency, Estimate of Possible Loss
VERU INC. (VERU) had Loss Contingency, Estimate of Possible Loss of $10.00 million as of 2019-12-31, per its 10-Q filed 2020-02-12.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2020-02-12
- 2019-12-31: Loss Contingency, Estimate of Possible Loss $10.00M.
- 2019-06-30: Loss Contingency, Estimate of Possible Loss $10.00M.
- 2019-03-31: Loss Contingency, Estimate of Possible Loss $10.00M.
- 2018-12-31: Loss Contingency, Estimate of Possible Loss $10.00M.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2019-12-31 | $10.00M 10-Q · filed 2020-02-12 |
| 2019-06-30 | $10.00M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $10.00M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $10.00M 10-Q · filed 2019-02-13 |
| 2018-09-30 | $10.00M 10-K · filed 2018-12-13 |
| 2018-06-30 | $10.00M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $10.00M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $10.00M 10-Q · filed 2018-02-14 |
| 2017-09-30 | $10.00M 10-K · filed 2018-01-02 |
| 2017-06-30 | $10.00M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $10.00M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $10.00M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $10.00M 10-K · filed 2016-12-12 |
| 2016-06-30 | $10.00M 10-Q · filed 2016-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |